US2014066620A1PendingUtilityA1
Pyrimidine substituted purine derivatives
Est. expiryOct 5, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 37/02A61P 37/00A61P 37/06A61P 35/02A61P 37/08A61P 35/00A61P 27/02A61P 29/00A61P 21/04A61P 11/00A61P 17/00A61P 1/00C07D 473/40C07D 413/14C07D 473/32C07D 487/04A61K 31/52
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with PI3 and/or mTOR kinases.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . (canceled)
2 . A pharmaceutical composition comprising:
or a pharmaceutically acceptable salt or prodrug thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.